In conclusion, we demonstrated that recombinant human arginase (BCT-100) display good anticancer effects against bladder cancer via apoptosis and autophagy regulated by the ROS-activated AKT/mTOR signaling pathway. The gene discussed is MTOR; the disease is urinary bladder cancer.